In ₹ Crore except Per Share Latest Annual | MEDICO FY26 | MEDICAMEQ FY26 | HALEOSLABS FY26 | AAREYDRUGS FY26 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | ◆ 22.15× | 41.83× | 25.32× | 68.34× | 41.83× -47% | |
| P/B | ◆ 0.00× | 1.49× | 1.91× | 1.80× | 1.80× -100% | |
| EV/EBITDA | ◆ 0.89× | 21.75× | 12.22× | 44.46× | 21.75× -96% | |
| Market Cap | ₹0.1 Cr | ₹410 Cr | ₹438 Cr | ₹270 Cr | ₹410 Cr -100% | |
| Growth | ||||||
| Revenue CAGR 3Y | 13.69% | 11.97% | 1.89% | ◆ 96.26% | 11.97% +14% | |
| Revenue CAGR 5Y | — | — | 4.68% | — | 4.68% | |
| Net Income CAGR 3Y | 21.89% | -12.71% | 16.09% | ◆ 100.20% | 16.09% +36% | |
| Revenue YoY (latest Q) | ◆ 81.43% | 11.27% | -11.59% | -56.34% | -11.59% +803% | |
| Net Income YoY (latest Q) | ◆ 38.49% | 15.35% | -58.00% | -25.36% | -25.36% +252% | |
| Profitability | ||||||
| EBITDA Margin | 8.25% | 9.90% | ◆ 13.38% | 1.52% | 9.90% -17% | |
| Net Income Margin | ◆ 6.35% | 4.95% | 5.33% | 0.84% | 4.95% +28% | |
| Return on Common Equity | ◆ 17.38% | 3.50% | 7.54% | 2.64% | 3.50% +397% | |
| Return on Capital Employed | ◆ 18.39% | 4.35% | 9.80% | 2.84% | 4.35% +323% | |
| Return on Assets | ◆ 8.55% | 2.63% | 3.92% | 1.33% | 2.63% +225% | |
| Credit & Quality | ||||||
| Total Debt/Equity | 0.25× | ◆ 0.17× | 0.47× | 0.33× | 0.33× -24% | |
| Interest Coverage | ◆ 7.71× | 3.54× | 4.53× | 0.86× | 3.54× +118% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹206 Cr | ₹198 Cr | ₹334 Cr | ₹472 Cr | ₹334 Cr -38% | |
| Net Income | ₹13.1 Cr | ₹9.8 Cr | ₹17.8 Cr | ₹4 Cr | ₹9.8 Cr +34% | |
| Total Assets | ₹153 Cr | ₹372 Cr | ₹454 Cr | ₹297 Cr | ₹372 Cr -59% | |
| EPS | ₹1.58 | ₹7.22 | ₹57.26 | ₹1.39 | ₹7.22 -78% | |
| Book Value per Share | ₹26,774.83 | ₹203.17 | ₹759.29 | ₹52.86 | ₹203.17 +13079% | |